ProLung, Inc. presents highest combined sensitivity and specificity values for a truly non-invasive lung cancer solution pursuing FDA clearance at ISRD & ATS joint medical conference

ProLung, Inc. presents highest combined sensitivity and specificity values for a truly non-invasive lung cancer solution pursuing FDA clearance at ISRD & ATS joint medical conference Salt Lake City, UT, October 31, 2019 – ProLung, Inc. (“ProLung” or the “Company”) and its long-time partner ProLung China (a Delaware, USA-based company), both whom are focused on [...]

ProLung, Inc. presents highest combined sensitivity and specificity values for a truly non-invasive lung cancer solution pursuing FDA clearance at ISRD & ATS joint medical conference2019-11-08T17:13:35-07:00

ProLung, Inc. Announces Large Clinical Validation Trial Results of 84% sensitivity and 74% specificity

ProLung, Inc. Announces Large Clinical Validation Trial Results of 84% sensitivity and 74% specificity Salt Lake City, UT, October 3, 2019 – ProLung, Inc. (“ProLung” or the “Company”) and its long-time partner ProLung China (a Delaware, USA-based company), both whom are focused on reducing the time to diagnosis for lung cancer patients, proudly announced today [...]

ProLung, Inc. Announces Large Clinical Validation Trial Results of 84% sensitivity and 74% specificity2019-10-31T07:51:09-07:00

ProLung Promotes Jared Bauer from interim CEO to CEO

ProLung Promotes Jared Bauer from interim CEO to CEO Salt Lake City, UT, October 2, 2019 – ProLung, Inc. (“ProLung” or the “Company”), which is focused on reducing the time to diagnosis for lung cancer patients, announced today the promotion of Mr. Jared Bauer from interim CEO to CEO. Mr. Bauer joined ProLung in July [...]

ProLung Promotes Jared Bauer from interim CEO to CEO2019-10-31T07:51:09-07:00

ProLung Announces the Appointment of Leavitt Partners and Mr. Rich McKeown to its Board of Directors

ProLung Announces the Appointment of Leavitt Partners and Mr. Rich McKeown to its Board of Directors Salt Lake City, UT, August 12, 2019 – ProLung, Inc. (“ProLung” or the “Company”), which is focused on reducing the time to diagnosis for lung cancer patients, announced today the appointment of Leavitt Partners to the ProLung Board of [...]

ProLung Announces the Appointment of Leavitt Partners and Mr. Rich McKeown to its Board of Directors2019-11-08T17:22:18-07:00

ProLung interim CEO, Jared Bauer, is a “Top Creative Leader Innovating in Business 2019” by Insights Success Magazine – ProLung, Inc.

ProLung interim CEO, Jared Bauer, is a “Top Creative Leader Innovating in Business 2019” by Insights Success Magazine – ProLung, Inc. ProLung is proud to share that our interim CEO, Jared Bauer, has been highlighted as a "Top Creative Leader Innovating in Business 2019" by Insights Success Magazine. Follow the link to learn more about [...]

ProLung interim CEO, Jared Bauer, is a “Top Creative Leader Innovating in Business 2019” by Insights Success Magazine – ProLung, Inc.2019-11-08T17:22:00-07:00

ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech Expertise – ProLung, Inc.

ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech Expertise – ProLung, Inc. Salt Lake City, UT, June 12, 2019 – ProLung, Inc. (“ProLung” or the “Company”), which is focused on reducing the time to diagnosis for lung cancer patients, announced the appointments of Messers. Jim Hogan, David Nielsen [...]

ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech Expertise – ProLung, Inc.2019-11-08T17:21:42-07:00

ProLung Announces New Office Location as Anchor Tenant at ‘The Labs at Northgate’ – ProLung, Inc.

ProLung Announces New Office Location as Anchor Tenant at 'The Labs at Northgate' – ProLung, Inc. SALT LAKE CITY, UT / ACCESSWIRE / June 10, 2019 / ProLung, Inc. ("ProLung" or the "Company"), which is focused on reducing the time to diagnosis for lung cancer patients, announced today it has started construction on a new [...]

ProLung Announces New Office Location as Anchor Tenant at ‘The Labs at Northgate’ – ProLung, Inc.2019-11-08T17:21:22-07:00

ProLung named Med Tech Company of the Year 2019 by Global Health & Pharma – ProLung, Inc.

ProLung named Med Tech Company of the Year 2019 by Global Health & Pharma – ProLung, Inc. ProLung is delighted to be honored as the “Med Tech Company of the Year 2019” by Global Health & Pharma. Our ProLung team views external recognition as further validation of our mission to ‘make a difference in time’ [...]

ProLung named Med Tech Company of the Year 2019 by Global Health & Pharma – ProLung, Inc.2019-11-08T17:21:04-07:00

ProLung Announces Preliminary Results from its PL-208 Clinical Trial and Next-Steps – ProLung, Inc.

ProLung Announces Preliminary Results from its PL-208 Clinical Trial and Next-Steps – ProLung, Inc. Salt Lake City, UT, February 1, 2019 – ProLung, Inc. (“ProLung” or the “Company”), which is focused on reducing the time to diagnosis for lung cancer patients with its ProLung Test™, yesterday announced the preliminary results of its PL-208 Validation Study [...]

ProLung Announces Preliminary Results from its PL-208 Clinical Trial and Next-Steps – ProLung, Inc.2019-11-08T17:19:37-07:00

ProLung named one of 50 Leading Companies of the Year 2018 by Silicon Review – ProLung, Inc.

ProLung named one of 50 Leading Companies of the Year 2018 by Silicon Review – ProLung, Inc. ProLung, Inc. is honored to be named one of the ‘50 leading companies of the year 2018’ by Silicon Review. Furthermore, our interim CEO, Mr. Jared Bauer, is interviewed in their end of the year special issue where [...]

ProLung named one of 50 Leading Companies of the Year 2018 by Silicon Review – ProLung, Inc.2019-11-08T17:19:19-07:00